Article Details
Retrieved on: 2022-12-15 15:46:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer also threw its hat into this ring at an R&D update this week, detailing two oral GLP-1 projects, one of which it will take into phase 3.
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here